| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.2M | -90.6% |
| R&D Expense | $16.5M | -54.7% |
| SG&A Expense | $23.8M | +45.3% |
| Operating Income | -$38.1M | -31.7% |
| Interest Expense | $315K | +4.5% |
| Pre-tax Income | -$42.2M | -125.5% |
| Income Tax | $0 | -100.0% |
| Net Income | -$42.2M | -125.1% |
| EPS (Basic) | -$7.64 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.6M | +275.9% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $58.9M | +166.6% |
| Total Assets | $83.9M | +64.9% |
| Current Liabilities | $10.8M | -27.9% |
| Total Liabilities | $26.6M | +34.2% |
| Stockholders' Equity | $57.3M | +84.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.1M | -7.1% |
| Capital Expenditures | $197K | -90.9% |
| Investing Cash Flow | -$153K | +92.7% |
| Financing Cash Flow | $66.8M | +6250.8% |
| Free Cash Flow | -$25.3M | +1.2% |
| -1676.7% |
| EPS (Diluted) | -$7.64 | -77.3% |